Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin B3 may help prevent hair loss and promote hair growth by protecting scalp cells from stress and reducing hair growth-blocking proteins.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

A rare case of hair loss was linked to breast cancer spreading to the scalp, but treatment was effective.

CTP-543 is generally safe for treating alopecia areata.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

Cancer treatments often cause skin, nail, and hair problems.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

Finasteride helps female-pattern hair loss.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.

Cooling can protect hair follicles from chemotherapy damage by reducing drug uptake.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Nanoparticle-embedded microneedles improve drug delivery through the skin but face challenges in stability and safety.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

PRAME helps distinguish between benign and malignant skin cells in most cases.